BioCube Financials
| BICB Stock | USD 0.0002 0.00 0.00% |
BioCube |
Understanding current and past BioCube Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioCube's financial statements are interrelated, with each one affecting the others. For example, an increase in BioCube's assets may result in an increase in income on the income statement.
Please note, the presentation of BioCube's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioCube's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of BioCube's management manipulating its earnings.
BioCube Stock Summary
BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. Biocube is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 1531 Smithtown Avenue, |
| Sector | Financial Services |
| Industry | Shell Companies |
| Benchmark | Dow Jones Industrial |
| Phone | 888 827 7901 |
| Currency | USD - US Dollar |
BioCube Key Financial Ratios
BioCube's financial ratios allow both analysts and investors to convert raw data from BioCube's financial statements into concise, actionable information that can be used to evaluate the performance of BioCube over time and compare it to other companies across industries.BioCube Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioCube's current stock value. Our valuation model uses many indicators to compare BioCube value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioCube competition to find correlations between indicators driving BioCube's intrinsic value. More Info.BioCube is rated second in current valuation category among its peers. It is rated third in shares outstanding category among its peers creating about 11.69 of Shares Outstanding per Current Valuation. Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCube by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCube's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioCube Systematic Risk
BioCube's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioCube volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on BioCube correlated with the market. If Beta is less than 0 BioCube generally moves in the opposite direction as compared to the market. If BioCube Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioCube is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioCube is generally in the same direction as the market. If Beta > 1 BioCube moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for BioCube Pink Sheet analysis
When running BioCube's price analysis, check to measure BioCube's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCube is operating at the current time. Most of BioCube's value examination focuses on studying past and present price action to predict the probability of BioCube's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCube's price. Additionally, you may evaluate how the addition of BioCube to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |